Vernalis

Vernalis is a leading drug discovery partner specializing in fragment- and structure-based drug discovery. Working with biotechnology and pharmaceutical organizations worldwide, Vernalis provides integrated expertise across protein science, hit identification and validation, biophysics, structural biology, medicinal chemistry, cell biology, and DMPK. Through collaborative partnerships and innovative discovery approaches, the company helps accelerate the progression of challenging therapeutic targets from early discovery to preclinical development. Operating from its research facilities in Cambridge, UK, Vernalis supports partners in advancing the next generation of innovative medicines.